Emmanuel O. Fadiran

Dialogues on Diversifying Clinical Trials: Successful Strategies for Engaging Women and Minorities in Clinical Trials

Meghan F. Coakley, Emmanuel O. Fadiran, L. Jo Parrish et al. · Journal of Women s Health · 2012 · 187 citations · Full text

Medicine, Biomedical Sciences, Clinical Pharmacology +12

Participation of Women and Sex Analyses in Late-Phase Clinical Trials of New Molecular Entity Drugs and Biologics Approved by the FDA in 2007–2009

Rita Poon, Keshav Khanijow, Sphoorti Umarjee et al. · Journal of Women s Health · 2013 · 100 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Demographics of Clinical Trials Participants in Pivotal Clinical Trials for New Molecular Entity Drugs and Biologics Approved by FDA From 2010 to 2012

Noha Eshera, Hawi Itana, Lei Zhang et al. · American Journal of Therapeutics · 2015 · 84 citations

Pharmacy, Pharmacology, Clinical Pharmacology +15

FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug‐Drug Interactions: Impact on Labeling

Barbara M. Davit, Kellie S. Reynolds, Rae Yuan et al. · The Journal of Clinical Pharmacology · 1999 · 74 citations

Medicine, Pharmacokinetics, Pharmacology +17

Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015

Alice Chen, Hilary Wright, Hawi Itana et al. · Journal of Women s Health · 2017 · 39 citations · Full text

Medicine, Pharmacology, Clinical Trial Regulation +15